baber/WOPTO huggingface dataset:
Patent DK-1259125-T3 (DK)
Inventor: FRIPPIAT ANNE
IPC: A23K1/16
Filed: 2001-02-14
Granted: 2006-09-04
Abstract: The invention relates to novel inulin products and compositions thereof, to their manufacture and to their use for modulating the bacterial flora and the fermentation pattern of inulin in the large intestine of humans and mammals, to their use for providing improved inulin-associated nutritional effects/benefits, and to their use for the manufacture of a pharmaceutical composition for providing said effects/benefits in humans and mammals. The novel inulin products consist of a mixture of an easily fermentable inulin (EFI) component (preferably an oligofructose, an agave inulin, or a mixture thereof) and a hardly fermentable inulin (HFI) component (preferably a long-chain inulin with a (DP) ≥ 20, typically chicory inulin with a (DP) ≥ 23), in a weight ratio ranging from 10/90 to 70/30. The nutritional effects include improved mineral absorption, particularly calcium and magnesium, bone mineral density increase, reduction of bone mineral density loss, improvement of bone structure, modulation of lipid metabolism, stimulation of the immune system, and anti-cancer effects. The novel inulin products are particularly suitable for the manufacture of a composition or a medicament for preventing, for postponing and for treating osteoporosis in humans, particularly postmenopausal women.
Patent DK-1313740-T3 (DK)
Inventor: SIMON WOLFGANG-ALEXANDER
IPC: A61K31/437
Filed: 2001-03-28
Granted: 2006-04-03
Abstract: Compounds of formula 1, in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
Patent DK-1419342-T3 (DK)
Inventor: YANG MAN HO
IPC: F21V23/04
Filed: 2002-01-28
Granted: 2008-02-04
Abstract: The invention relates to a push-button arrangement with a housing, a housing opening, a press switch element, a pushbutton facing out of the housing opening, and an elastically deformable hood or cap. The hood or cap has a hood edge which engages from the rear with the opening, and has an inner wall and an insertion ring. The insertion ring has an insertion height and an angular outer ring wall which can be adapted to the inner wall of the cap, and which can be completely received in the hood between the inner hood wall and the pushbutton, and which diameter can be elastically varied section by section along the height of the insertion ring.
Patent DK-1425080-T3 (DK)
Inventor: BUCKETT JONATHAN
IPC: B01D33/073
Filed: 2002-09-10
Granted: 2008-06-09
Abstract: A liquid filtering apparatus for mounting in a housing and positioned to filter liquid flowing from an inlet ( 23 ) to a drain. A rotatable wheel is disposed within and coupled to a rotating screen so that rotation of the wheel causes rotation of the screen. The wheel includes vanes ( 5-12 ) extending towards the screen dividing the space within the screen into sections substantially isolated from each other except via the drain. A stationary baffle ( 13 ) arranged adjacent a portion of the screen prevents liquid from flowing into the wheel through that screen portion. The baffle is positioned such that water flows more readily into sections of the wheel on one side of a vertical plane through the rotation axis than the other sections. Thus, the wheel is unbalanced by water retained in sections of the wheel and rotation of the wheel results.
Patent DK-1390022-T3 (DK)
Inventor: GRISTWOOD ROBERT WILLIAM
IPC: A61P25/04
Filed: 2002-05-21
Granted: 2007-08-13
Abstract: 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof is useful for the treatment of pain.
Patent DK-1434540-T3 (DK)
Inventor: HANSEN PALLE M
IPC: A61F2/84
Filed: 2002-10-09
Granted: 2006-11-20
Abstract: A stent ( 30 ) formed from cannula and having flexible segments ( 31 ) and high hoop strength segments ( 32 ) alternating therealong. Longitudinal struts or tie bars ( 41 ) interconnect the segments. Minimal length reduction of the strut occurs upon expansion. In the high hoop strength segment ( 32 ), struts ( 37 ) in a zig-zag configuration (Gianturco Z-stent) are initially parallel in the unexpanded strut condition. In the flexible segment ( 31 ), struts ( 58 ) extend from a respective C-shaped bend ( 59 ) to converge at the opposite ends thereof when unexpanded. In one embodiment, certain adjacent struts ( 39-41 ) of the hoop segment are spaced apart by elongated openings or gaps ( 46, 48 ) interposed therebetween and interconnected at their respective ends ( 42, 44 ) to form a T-shaped strut interconnection ( 45 ). The selected width ( 50, 51 ) of the first and third struts ( 54, 57 ) increases toward the ends ( 47, 48 ) of the elongated openings ( 46, 48 ) adjacent the strut interconnection ( 45 ). This strut width increase about one end of the strut significantly reduces the tensile strain exhibited about the opening end when the stent is radially expanded during manufacture. The tip length ( 52, 55 ) of the struts about the interconnection ( 45 ) is also adjusted (increased) along with the other C-shaped strut interconnections ( 59, 71 ) to further distribute the tensile strain developed during radial expansion.
Patent DK-1437969-T3 (DK)
Inventor: ASCULAI SAMUEL S
IPC: A61B/
Filed: 2002-10-03
Granted: 2011-05-02
Abstract: An implantable article for cartilage repair by implantation in an animal. The implantable article includes a support matrix, and chondrocyte cells and a bio-compatible adhesive adhered to an edge of the support matrix, wherein the support matrix is absorbable by the animal. The support matrix is a biocompatible material such as collagen, and the adhesive is autologous fibrin.
Patent DK-1398261-T3 (DK)
Inventor: SUTHERLAND SCOTT
IPC: B60R19/42
Filed: 2003-08-25
Granted: 2011-10-03
Abstract: The motor cycle trailer has a chassis and at least one bumper (8,9,11) arranged on the outside of a frame part (1) of the chassis and protruding beyond the frame part in at least one direction. The structural height of the bumper is greater than that of the frame part. The bumper protrudes beyond at least one edge or end of the frame part.
Patent DK-1519681-T3 (DK)
Inventor: BREEN ALAN INS FOR MUSCULOSKE
IPC: A61B6/04
Filed: 2003-07-08
Granted: 2007-04-10
Abstract: Apparatus provided for the measurement of skeletal joint motion in a subject which comprises a passive motion device, an imaging device and a processing system incorporating a means for real time digital sampling of images of moving joints, means for recognizing templates attributed to individual bones and tracking these automatically using cross-correlation functions and means for geometric transformation of the positional data to graphically display their relative motion over time. Also provided is a method for the automated measurement of the relative motion of skeletal structures in vivo using such apparatus and a method for the diagnosis of a pseudoarthrosis in a subject which comprises the use of such apparatus.
Patent DK-1563160-T3 (DK)
Inventor: MOE MAGNE MATHIAS
IPC: E21B1/00
Filed: 2003-11-13
Granted: 2006-10-16
Abstract: A device for tensioning and relieving production tubing ( 49 ) extending from a subsea hydrocarbon well ( 107 ) up through a riser ( 63 ) to a floating installation ( 87 ), a continuous production tubing extension ( 85 ) passing through a telescopic unit ( 67 ) in the upper part of the riser ( 63 ), preferably extending above a production deck ( 89 ) on the floating installation ( 87 ), where the production tubing ( 49 ) is provided with a tubing tensioner unit ( 1 ) below and in the proximity of the lower end of the telescopic unit ( 67 ).
Patent DK-1460102-T3 (DK)
Inventor: APICHATACHUTAPAN WASSANA
IPC: B29C44/04
Filed: 2004-01-16
Granted: 2007-03-26
Abstract: The subject invention provides a method of forming high resilience slabstock polyurethane foam having random cell structures to produce latex-like feel and characteristics. The method includes the first step of providing an isocyanate-reactive component and an isocyanate component substantially free of toluene diisocyanate comprising diphenylmethane-2,4'-diisocyanate present in an amount of from 15 parts by weight to 55 parts by weight based on 100 parts by weight of the isocyanate component and diphenylmethane-4,4'-diisocyanate present in an amount from 45 parts by weight to 85 parts by weight based on 100 parts by weight of the isocyanate component to react with the isocyanate-reactive component. A first nucleation gas is provided under low pressure and is added into at least one of the isocyanate-reactive component and the isocyanate component to produce a first cell structure in the polyurethane foam. A second nucleation gas different than the first nucleation gas is provided under low pressure and is added into at least one of the isocyanate-reactive component and the isocyanate component to produce a second cell structure in the polyurethane foam different than the first cell structure. <IMAGE>
Patent DK-1677628-T3 (DK)
Inventor: VIGNUTELLI ALBERTO
IPC: A23L33/15
Filed: 2004-09-18
Granted: 2010-07-05
Abstract: The invention relates to pharmaceutical composition or dietary supplement for the activation of the immune system essentially consisting of: (i) an extract of Panax ginseng; (ii) vitamin C and vitamin E; (iii) selenium; (iv) optionally one or more minerals selected from copper and zinc; (v) optionally arginine; and (vi) a pharmaceutically acceptable carrier.
Patent DK-1671511-T3 (DK)
Inventor: BLOM ROLF
IPC: H04L9/32
Filed: 2004-09-10
Granted: 2011-10-03
Abstract: A basic idea according to the invention is to enhance or update the basic cryptographic security algorithms by an algorithm-specific modification of the security key information generated in the normal key agreement procedure of the mobile communication system. For communication with the mobile terminal, the network side normally selects an enhanced version of one of the basic cryptographic security algorithms supported by the mobile, and transmits information representative of the selected algorithm to the mobile terminal. The basic security key resulting from the key agreement procedure (AKA, 10) between the mobile terminal and the network is then modified (22) in dependence on the selected algorithm to generate an algorithm-specific security key. The basic security algorithm (24) is then applied with this algorithm-specific security key as key input to enhance security for protected communication in the mobile communications network.
Patent DK-1571217-T3 (DK)
Inventor: QUAX WILHELMUS J
IPC: C12N9/90
Filed: 1998-07-15
Granted: 2009-07-06
Abstract: The present invention relates to secretion in Gram-positive microoganisms. The present invention provides the nucleic acid and amino acid sequences for the Bacillus subtilis disulfide bond isomerase Dsb2. The present invention also provides means for increasing the secretion of heterologous or homologous proteins in gram-positive microorganisms.
Patent DK-1716152-T3 (DK)
Inventor: XIN TAO
IPC: C07D487/00
Filed: 2005-02-17
Granted: 2008-11-03
Abstract: The present invention is directed to compounds of formula: (I); wherein X<SUP>1</SUP>, X<SUP>2</SUP>, X<SUP>3</SUP>, X<SUP>4</SUP>, X<SUP>5</SUP>, X<SUP>6</SUP>, X<SUP>7</SUP>, X<SUP>8</SUP>, X<SUP>9</SUP>, X<SUP>10</SUP>, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, and n are as defined for formula I in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds for treating gastrointestinal disorders.
Patent DK-1745063-T3 (DK)
Inventor: RONALD FRANK
IPC: C07K1/04
Filed: 2005-05-12
Granted: 2009-03-16
Abstract: A method of producing a microarray, the microarray itself and the use of the microarray for detecting interactions between probe molecules and analyte molecules from a sample is provided. The method comprises the steps of synthesis, in two or more stages, of probe molecules on a polymeric support, bonds being formed between the probe molecules and the polymeric support; dispersion of the polymeric support having the synthetic probe molecules, the bonds between the polymeric support and the probe molecules being retained; optional purification of the probe molecules bound to the polymeric support; dissolution of the polymeric support having the bound probe molecules; and application of the solution containing the polymeric support having the bound probe molecules in the form of microdrops to a planar surface.
Patent DK-1789398-T3 (DK)
Inventor: MERCKEN MARC HUBERT
IPC: A61P25/28
Filed: 2005-08-08
Granted: 2011-01-24
Abstract: The present invention is directed to novel 2-amino-3,4-dihydro­quinazoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of ß-secretase, also known as ß-site cleaving enzyme and BACE.
Patent DK-1736144-T3 (DK)
Inventor: TABATA TETSURO
IPC: A61K47/38
Filed: 1999-05-17
Granted: 2015-12-07
Abstract: An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 mu m or less, which fine granules comprise a composition coated by an enteric coating layer, said composition having 10 weight % or more of an acid-labile physiologically active substance and (ii) an additive, has superior disintegrability or dissolution in the oral cavity so that it can be used for treatment or prevention of various diseases, as an orally disintegrable tablet capable of being administered to the aged or children and easily administered without water. Also, because the tablet of the present invention contains fine granules having the average particle diameter such that it will not impart roughness in mouth, it can be administered easily without discomfort at the administration.
Patent DK-1848446-T3 (DK)
Inventor: TANNER-BAUMGARTNER JESSICA
IPC: A61K33/26
Filed: 2006-01-18
Granted: 2010-02-15
Abstract: The present invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof, in the preparation of a medicament for improving immune defense and/or brain performance.
Patent DK-1976455-T3 (DK)
Inventor: HO ARTHUR
IPC: A61F9/01
Filed: 2007-01-11
Granted: 2018-04-16
Abstract: A method and apparatus are disclosed for controlling optical aberrations to alter relative curvature of field by providing optical devices and methods comprising the repositioning of peripheral off-axis focal points relative to the retina to produce stimulus for influencing the progression of refractive error while simultaneously controlling the position of the central focal point near to the retina to provide clear central vision and simultaneously providing zones of controlled peripheral defocus and other optical aberrations to improve peripheral vision for select directions of gaze.
Patent DK-2229949-T3 (DK)
Inventor: MOELLSTAM BO
IPC: A23L1/30
Filed: 2005-06-14
Granted: 2012-02-06
Abstract: The invention herein relates to the use of nonpathogenic, antiinflammatory and anti-bleeding lactic acid bacteria strains, and products and methods using such strains for treatment and prophylaxis of bleeding gum and gingivitis caused by oral inflammation.
Patent DK-2555787-T3 (DK)
Inventor: ANTONY BENNY
IPC: A61K36/9066
Filed: 2011-04-04
Granted: 2018-01-29
Abstract: Invention relates to a formulation of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin and to augment the biological activity of curcumin, wherein curcumin is the main constituent of curcuminoid and wherein Ar-turmerone is the main constituent of the essential oil of turmeric. The invention relates to an application of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin for oral supplementation against a variety of diseases and method of doing the same.
Patent DK-2781212-T3 (DK)
Inventor: BECKER REINHARD
IPC: A61K47/26
Filed: 2011-05-17
Granted: 2018-07-23
Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.
Patent DK-2216416-T3 (DK)
Inventor: LICHTENSTEIN ANATOLY V
IPC: C07H21/04
Filed: 1998-05-29
Granted: 2012-08-27
Abstract: A method of analysing a target nucleic acid sequence in a urine sample, said method comprising assaying said urine sample for the presence of said target nucleic acid sequence that has crossed the kidney barrier. The present invention provides a method for detecting a non-host nucleic acid sequence in a patient, said method comprising assaying a urine sample, obtained from an individual, for a nucleic acid sequence that: 
(i) is from outside the urinary tract, 
(ii) has crossed the kidney barrier, and 
(iii) does not originate from the patient's endogenous nucleic acid sequences, wherein contaminating nucleic acids in the urine sample comprising greater than 1000 base pairs, or 1000 nucleotides when denatured are removed from the sample prior to detection of said non-host nucleic acid.
Patent DK-0380004-T3 (DK)
Inventor: SOLTIC JOSIP
IPC: B61D17/20
Filed: 1990-01-20
Granted: 1992-11-23
Abstract: The extension is provided for railway vehicles, in particular for passenger coaches with UIC hitches and buffer gear and junction devices whose dividing planes can slide on one another with pretensioning and which in the non-loaded state protrude beyond their own buffer plate plane. The extension has buffer deflection means (11) which are provided for mirror-inverted attachment on the left and right of a junction device (17) in order to protect its components from collision with extraneous buffers. Normally, these means (11) have essentially three adjacent, preferably plane, surface components (21, 31, 41) in a position arranged at right angles to one another. However, they may also have only two faces, namely a pushing face (31) and an impact face (41) or in each case only one continuous spatial face structure (31, 41, 21, 31, 41). By means of this extension, passenger coaches with UIC hitches and buffer gear which have junction devices of a design which is pressure wave-resistant for high-speed transport and whose dividing planes can slide on one another with pretensioning and protrude in the non-loaded state beyond their own buffer plate plane, are protected from collisions with extraneous buffers. <IMAGE>
Patent DK-0416210-T3 (DK)
Inventor: JAEKEL WOLFGANG DIPL-ING FH
IPC: A47B96/06
Filed: 1990-05-15
Granted: 1997-10-13
Abstract: A wall cabinet has a profile made of metal, in particular light metal, which profile has a rectangular, closed main part (29). A fluted web (33) projects from the centre of one narrow side (31) of the main part (29). Projecting from the edges of said narrow side (31) and extending parallel to the fluted web (33) are edge webs (32) which are shorter than the fluted web. A box part (36), which is smaller than the main part (29), adjoins the main part (29) on the narrow side (35) facing away from the fluted web. This profile is used as edging for chipboards, from which the construction shelves of the wall cabinet and its side walls are constructed. The profile is to be attached to the associated side edge of the relevant chipboard by knocking the fluted web into the end face of the chipboard. A number of fittings are also provided for constructing the wall cabinet. <IMAGE>
Patent DK-0384889-T3 (DK)
Inventor: SCHURTER ROLF DR
IPC: C07D417/06
Filed: 1990-02-13
Granted: 1993-11-15
Abstract: Novel N-acyl- and N-sulfonylbenzo-1,2,3-thiadiazole-7-carboxylic acid amides of formula   <IMAGE> (I)  in which X1 and X2 independently of one another are each hydrogen or together 1 to 3 halogen atoms; A is sulfonyl or carbonyl; Y is phenyl or phenyl substituted by C1-C2alkyl, C1-C2alkoxy, halogen, C1-C2haloalkyl, C1-C2alkoxycarbonyl, C1-C3alkanoyloxymethyl, cyano and/or by nitro; R is hydrogen, C1-C4alkyl, C1-C4haloalkyl, C3-C5alkenyl or C3-C5alkynyl; and in which, furthermore, the group  <IMAGE>  <IMAGE> <IMAGE>  wherein A1 is methylene, carbonyl or sulfonyl; X3 is hydrogen, methyl or halogen; m is 2, 3 or 4; and n is zero, 1 or 2. The novel active ingredients have plant-protecting properties and are suitable especially for the preventive protection of plants against attack by phytopathogenic microorganisms such as fungi, bacteria and viruses.
Patent DK-0465975-T3 (DK)
Inventor: WIDMER FREDI
IPC: E03D9/02
Filed: 1991-07-01
Granted: 1995-03-13
Abstract: A container (100) capable of suspension in a toilet bowl and constructed so as to receive a water-soluble block (colour stick) is proposed, which container essentially comprises a shell body (10), a lid (50) articulated thereon and provided with a basket part (56) for the admission of water, and a correspondingly constructed closure member (30). The shell body (10) and the lid (50) are provided, on the side opposite a common rear wall (14, 54), in each case with a conically widening end wall (15, 55). A stopper (70) is arranged on the inner side of the end wall (55) of the lid (50) between two catch elements (60, 60') arranged at a distance from one another, and the closure member (30) as well as two catch devices (65, 65') are provided on the inner side of the end wall (15) of the shell body (10). When closed, the stopper (70) is arranged sealingly in the closure member (30) acting like a syphon, and the lid (50) is detachably fastened to the shell body (10) by means of the catch elements (60, 60') snapping into the catch device (65, 65'). <IMAGE>
Patent DK-0467806-T3 (DK)
Inventor: MAIRE JACQUES
IPC: B01D69/10
Filed: 1991-07-15
Granted: 1995-12-27
Abstract: Support for a membrane capable of being employed for separation techniques, consisting of a carbon-carbon composite material of small thickness in the Z direction of passage of the flow to be treated, mechanically robust, with a porous texture appropriate to the membrane, comprising a fibrous substrate and a porous carbonaceous matrix, and characterised in that, with the aim of increasing the permeability and reducing the roughness of the outer face of the support which is intended to be in contact with the said membrane, the fibrous substrate is a mat of carbon fibres, consisting of segments of carbon fibres contained in a plane perpendicular to the Z axis and oriented randomly in this plane and in that, if appropriate, a fraction of the support which is intended to be in contact with the said membrane contains a dispersion of fine inert powder which makes it possible to adjust the diameter of the pores of the said outer face of the support. Process for the manufacture of this support for a membrane and its use as a membrane support and as filter element without any membrane being added. 
<IMAGE>
Patent DK-0506821-T3 (DK)
Inventor: FOSTER DONALD C
IPC: C07K14/745
Filed: 1990-12-28
Granted: 1998-03-30
Abstract: Human protein C molecules are modified to provide increased resistance to inactivation by human plasma factors while retaining substantially the biological activity of human protein C. The modifications are generally to the heavy chain of protein C, which chain may be substituted with a protein C heavy chain of non-human origin, such as bovine, yielding a chimeric protein C molecule. The human protein C heavy chain may also be modified to be human-like, in that at least one amino acid from a non-human sequence may be substituted for the corresponding residue(s) of the human sequence, thereby allowing the molecule to retain substantially human characteristics yet having increased resistance to inactivation. Also included are methods for producing the modified protein C molecules and pharmaceutical compositions thereof. The modified molecules, having an increased half-life in human plasma, are particularly useful for treating coagulation-related disorders, such as protein C deficiency or thrombosis, or for promoting fibrinolysis in a patient.